pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 10·1 min read
save

Shattuck Labs raises $75M in public offering, selling 10.5M shares at $4 each

Jun 10, 2026·read at Endpoints ↗DealNeutral

Shattuck Labs announced a $75 million public offering to raise capital.

The company is selling more than 10.5 million shares at $4 per share and is also issuing pre‑funded warrants to selected investors.

In a separate announcement, Servier entered into a partnership with the n‑Lorem Foundation to develop a neuro antisense oligonucleotide (ASO) program.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Shattuck raises $75M; Servier inks neuro ASO pact with n-Lorem Foundation”

read at Endpoints ↗
76 words · retrieved Jun 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Shattuck Labs, Inc.4SERVIER2n-Lorem Foundation
topics
Antisense Oligonucleotide (ASO)4Neurology2HER2

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • May 8Giants of Cancer Care Announces the 14th Annual Class of Inducteesonclive
  • May 8OncLive Weekly News Quiz (5/8/2026): Test Your Knowledge on Key Breast, Lung, and Pancreatic Cancer Updatesonclive
  • May 8OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive
  • May 8Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026onclive